Vitamin D Testing Market Size Worth $1.1 Billion by 2025 | CAGR: 9.4%: Grand View Research, Inc.

Monday, June 26, 2017 Research News
Email Print This Page Comment
Font : A-A+

SAN FRANCISCO, June 26, 2017 /PRNewswire/ --

The global vitamin D testing market is

expected to reach USD 1.1 billion by 2025, according to a new report by Grand View Research, Inc. Global increase in geriatric population as well as cases of chronic illnesses is likely to drive the market during the forecast
period. 

     (Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )

Furthermore, increase in investment for development and commercialization of various accurate, innovative, and easy-to-use tests by various market players and governments is likely to drive the market growth. For instance, in January 2017, Future Diagnostics and DIA source received a grant of EUR 1.4 million from the European Commission to develop a unique CE-marked assay that can measure the level of free vitamin D (25OHD) in the body. In addition, this assay will assist in early recovery of patients suffering from vitamin D deficiency by providing optimized treatment, offering an opportunity to save treatment costs.

Vitamin D assay measures the level of vitamin D in two forms. Hence, the market has been divided by two major types of tests, namely 25-Hydroxy Vitamin D test and 1, 25-Dihydroxy vitamin test.

The 5-hydroxy vitamin D tests or assay segment dominated in 2016 due to its greater ability to identify bone malformations, softness, weakness, and fractures in adults. Its domination is likely to continue in the forecast period as well.

Browse full research report with TOC on "Vitamin D Testing Market Analysis By Type of Test (25-Hydroxy Vitamin D Tests; 1, 25-Dihydroxy Vitamin D Tests), Region (North America, Europe, Asia Pacific, South & Central America, MEA), And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/vitamin-d-testing-market

Further key findings from the report suggest: 

  • Rising incidence of chronic illnesses and growing geriatric population are expected to propel the growth of the market with a CAGR of 9.4% from 2017 to 2025
  • 5-hydroxy vitamin D test segment accounted for the largest share and is anticipated to witness strong growth during the forecast period. This can be attributed to the availability of several commercial products, ongoing research in the field, and the ability to accurately detect bone malformations.
  • Geographically, North America held the largest share in 2016. It is expected to maintain its dominance during the forecast period due to higher awareness about screening, higher healthcare expenditure as compared to other developing countries, and local presence of market players.
  • The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to growing investments by several market players in the region, growing healthcare expenditure, and recent commercialization of tests in major markets, such as Japan and China
  • Some of the key players are Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Hologic, Inc.; Siemens Corporation; Danaher Corporation; Quest Diagnostics, Inc.; bioMérieux SA; and DiaSorin S.p.A. 

Browse related reports by Grand View Research: 

  • Cancer Pain Market - http://www.grandviewresearch.com/industry-analysis/cancer-pain-market
  • Genetic Disease Diagnostic Market - http://www.grandviewresearch.com/industry-analysis/genetic-disease-diagnostic- market
  • Diabetes Treatment Market - http://www.grandviewresearch.com/industry-analysis/diabetes-treatment-market
  • Asthma & COPD Market - http://www.grandviewresearch.com/industry-analysis/asthma-and-copd-market

Grand View Research has segmented the global vitamin D testing market on the basis of type of test and region: 

  • Type of Test Outlook (Revenue, USD Million, 2014 - 2025) 
    • 25-Hydroxy Vitamin D Tests
    • 1, 25-Dihydroxy Vitamin D Test
  • Regional Outlook (Revenue, USD Million, 2014 - 2025) 
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
    • Asia Pacific
      • China
    • Central & South America
      • Brazil
    • Middle East & Africa
      • South Africa

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: +1-888-202-9519 Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com

SOURCE Grand View Research, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook